Arm Holdings plc American Depositary Shares

Arm Holdings outlined its role in Nvidia's new agent security platform as its shares fell 7.6% to $286.79 around 9:57 a.m. ET Monday. Nvidia's OpenShell can run on Arm's Vera CPU, and the approach can extend to platforms such as AWS Graviton, Google Axion and Microsoft Cobalt. Arm based infrastructure processors can also monitor an agent's activity and enforce security rules separately from the processor running it, putting Arm technology on both sides of the setup. The announcement described a possible route to more chip demand rather than a new customer order, and the valuation leaves little room for a story that stays theoretical, with a GF Value of $194.76 putting Monday's $286.79 share price 47.25% above that estimate. More agent deployments could mean more Arm powered processors, but investors still need evidence that those deployments are turning into licensing and royalty growth.

A September 14 selloff treated slower frontier AI development as bad news for chips, but Reuters Breakingviews argued that a moderation in giant model-training runs could redirect part of this year's roughly $1 trillion AI investment toward inference, where existing models answer queries and run agents. That shift would create a different contest for Intel and Nvidia, because inference does not erase GPUs but broadens the bill of materials. Intel's opportunity is the server CPU, since production AI applications need orchestration, memory, networking and general-purpose compute around accelerators, and Intel reported $6.3 billion of Data Center and AI revenue in its latest quarter, up 59% year over year. Execution remains the risk: Intel is spending heavily to rebuild manufacturing leadership and still generated negative adjusted free cash flow in its latest quarter, and inference growth helps only if Intel keeps enough share and margin against AMD, Arm-based CPUs and specialized accelerators. Nvidia remains the strongest counterargument to a simple rotation thesis, since its GPUs run both training and inference and CUDA plus newer inference-focused systems give it a path to monetize deployed AI even if frontier training slows, with the downside relative rather than existential. Insider Monkey's database counted 138 hedge funds holding Intel in Q2 2026, up from 112 in Q1, with AQR Capital Management owning 10,742,567 shares after trimming its position 7%, while Nvidia rose to 285 funds from 275 and Fisher Asset Management increased its stake 3% to 90,935,947 shares, filings that predate the September 14 safety-driven market reaction. Intel had 152,248,752 shares sold short on August 31, equal to 3.02% of float, with 1.69 days to cover.

Arm Holdings CEO Rene Haas said artificial intelligence could help find a cure for cancer within our lifetime, but warned that chip shortages are limiting the expansion of AI infrastructure. In an interview with the BBC, Haas said AI could eventually solve complex problems in cancer research and accelerate drug development, though modelling cells and DNA markers remains too complex today. The computing requirements for AI-driven drug discovery are already substantial, with Generate Biomedicines co-founder Gevorg Grigoryan noting that large-scale model training needs access to many GPUs, plus proprietary biological data. Bristol Myers Squibb has deployed a new NVIDIA AI computing system to support research across cancer and other therapeutic areas. Haas described the industry as in an "absolutely supply-constrained environment," saying more chip factories are needed to support growing data centers, but manufacturing capacity cannot be added overnight. He also said Arm's power-efficient technology is used in about half of AI data centers worldwide, and demand for Arm's AGI chip, developed with Meta Platforms, has exceeded $2 billion since its launch.

Citi told clients in a note Tuesday that it expects semiconductor stocks to rebound after a summer slump, arguing that a heavy conference schedule and resilient data center demand should support the sector. The bank noted the Philadelphia Semiconductor Index fell 18% over the summer as the group ran into high expectations and a modest deceleration in earnings momentum. Even so, Citi looks for a recovery heading into its Global TMT conference, where it expects positive commentary led by AMD, MRVL, LITE, ALAB, and semi caps. Data center demand remains strong, accounting for 34% of the industry's total addressable market, while autos and industrials, at 21%, continue to recover. Demand from PCs and handsets, which make up 42% of the market, is said to remain weak amid memory cost inflation and supply constraints. The bank turned more bullish on central processing units after recent earnings and the Hot Chips conference, lifting its CPU market forecast to $237 billion by 2030 from $29 billion in 2025, a 52% compound annual growth rate, above forecasts from AMD, Arm and Nvidia. Citi expects AMD to be the key beneficiary of what it called a "CPU renaissance," with Intel a secondary winner. Furthermore, Citi raised its outlook for wafer fabrication equipment spending, citing a stronger hyperscaler capital expenditure model, now seeing a 2028 bull case approaching $300 billion, with base-case spending of $257 billion, up from $250 billion previously.

Arm Holdings CEO Rene Haas doubled the customer demand pipeline for the Arm AGI CPU to more than $2 billion across fiscal 2027 and 2028, up from the $1 billion opportunity flagged a quarter earlier. The company reported fiscal Q1 2027 revenue of $1.289 billion, up 22.4% and beating consensus, while GAAP EPS of $0.25 missed the $0.40 consensus estimate as R&D climbed to $838 million. 24/7 Wall St. set a price target of $284.95 on Arm, implying 4.98% upside from the current $271.43 price, and rates the stock a hold at 90% confidence. The bull case sees Arm reaching $428.74 in twelve months if AGI CPU shipments cross 10% of revenue and gross margins land in the high 30% to low 40% range, while the bear case takes the stock to $226.47 on smartphone royalty growth cut to high teens and an adverse Qualcomm ruling. Arm trades at 127 times forward earnings, compared with 25 times for NVIDIA, 21 times for Broadcom, and 16 times for Qualcomm.

Arista Networks reported quarterly revenue of $3.0 billion for the period ended June 30, 2026, marking the first time the company has reached that level. The result extended a pattern of consistent sequential revenue increases, with the company also generating a 40% net income margin and $1.1 billion in free cash flow for the quarter. That contributed to shares reaching a 52-week high of $214.89 in August. By comparison, Arm Holdings reported $1.3 billion in revenue for the same quarter, with a 21% net income margin and $694.0 million in free cash flow, though its stock has fallen since hitting a 52-week high of $452.70 in June.